Evidence map›Paper›PMID 29712757›Full record

ArticleMolecular and cellular biology2018

Defective Flux of Thrombospondin-4 through the Secretory Pathway Impairs Cardiomyocyte Membrane Stability and Causes Cardiomyopathy.

Matthew J Brody, Davy Vanhoutte, Tobias G Schips, Justin G Boyer, Chinmay V Bakshi, Michelle A Sargent, Allen J York, Jeffery D Molkentin

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Ankyrin-B is lipid-modified byFrontiers in physiology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Matthew J BrodyDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Davy VanhoutteDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Tobias G SchipsDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Justin G BoyerDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Chinmay V BakshiDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Michelle A SargentDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Allen J YorkDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA jeff.molkentin@cchmc.org.
Cincinnati Children's Hospital Medical Center · USHoward Hughes Medical Institute · US

Funding

Thrombospondin 4 regulates adaptive ER stress responseRenewal - Resubmission - 1R01HL105924 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Jeffery D Molkentin · 2011 to 2026
$7.3M
In vivo role of the fibroblast in muscular dystrophy-RenewalR01AR071301 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Jeffery D Molkentin, Davy Vanhoutte · 2018 to 2026
$2.4M
The role of palmitoylation in cardiac signal transduction and disease pathogenesisK99HL136695 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BRODY, MATTHEW JACOB · 2018 to 2019
$258k
The role of thrombospondin-4 in the secretory pathway, extracellular matrix produF32HL124698 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BRODY, MATTHEW JACOB · 2014 to 2017
$159k
NHLBI NIH HHS F32 HL124698NHLBI NIH HHS K99 HL136695NHLBI NIH HHS R01 HL105924NIAMS NIH HHS R01 AR071301
6 · The paper itself

Abstract

Thrombospondins are stress-inducible secreted glycoproteins with critical functions in tissue injury and healing. Thrombospondin-4 (Thbs4) is protective in cardiac and skeletal muscle, where it activates an adaptive endoplasmic reticulum (ER) stress response, induces expansion of the ER, and enhances sarcolemmal stability. However, it is unclear if Thbs4 has these protective functions from within the cell, from the extracellular matrix, or from the secretion process itself. In this study, we generated transgenic mice with cardiac cell-specific overexpression of a secretion-defective mutant of Thbs4 to evaluate its exclusive intracellular and secretion-dependent functions. Like wild-type Thbs4, the secretion-defective mutant upregulates the adaptive ER stress response and expands the ER and intracellular vesicles in cardiomyocytes. However, only the secretion-defective Thbs4 mutant produces cardiomyopathy with sarcolemmal weakness and rupture that is associated with reduced adhesion-forming glycoproteins in the membrane. Similarly, deletion of

Indexed as

AnimalsAnimals, Genetically ModifiedCardiomyopathiesCells, CulturedDrosophila melanogasterEndoplasmic Reticulum StressHumansMiceMice, 129 StrainMice, Inbred C57BLMice, Inbred mdxMice, KnockoutMice, TransgenicMuscular Dystrophy, AnimalMutationMyocytes, Cardiacthrombospondin 4Thrombospondinscardiomyopathyheartthromobospondintransgenic mice

Identifiers

PMID29712757
PMCPMC6024163
OpenAlexW2801464337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.